glp-1 chronic kidney disease Design and discovery of a highly potent ultralong-acting and glucagon co-agonist for attenuating renal fibrosis Chronic kidney disease in type

regulators to request the removal of suicide-related warnings from certain weight-loss and diabetes medications

GLP1-RAs are commonly used as a weight loss drug and side effects may include gastrointestinal issues such as nausea, vomiting, diarrhea, constipation and abdominal pain

How this article was created This article was prepared with the assistance of AI content tools and reviewed for accuracy against CMS.gov, Medicare.gov, and UnderstoodCare's internal program knowledge

These metabolic changes compound mechanical stress, potentially explaining why some patients develop or worsen back pain despite overall health improvements from weight loss

Johnstone M, Buddhdev P, Peter M, Diggory R

Kelvin (K): In the metric system, a graduated scale used to measure temperature with 0 (-273 C) being the total absence of heat (absolute zero)